These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 29115883)

  • 1. Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.
    Gudiol C; Cuervo G; Shaw E; Pujol M; Carratalà J
    Expert Opin Pharmacother; 2017 Dec; 18(18):1947-1963. PubMed ID: 29115883
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Davis KP; McDermott LA; Snydman DR; Aldridge BB
    Microbiol Spectr; 2024 Aug; 12(8):e0097624. PubMed ID: 38916355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia.
    Lewis PO; Heil EL; Covert KL; Cluck DB
    J Clin Pharm Ther; 2018 Oct; 43(5):614-625. PubMed ID: 30003555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.
    Purrello SM; Garau J; Giamarellos E; Mazzei T; Pea F; Soriano A; Stefani S
    J Glob Antimicrob Resist; 2016 Dec; 7():178-186. PubMed ID: 27889013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftaroline for the treatment of methicillin-resistant
    White BP; Barber KE; Stover KR
    Am J Health Syst Pharm; 2017 Feb; 74(4):201-208. PubMed ID: 28179245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
    Holubar M; Meng L; Deresinski S
    Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
    Schmidt-Ioanas M; de Roux A; Lode H
    Curr Opin Crit Care; 2005 Oct; 11(5):481-6. PubMed ID: 16175036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
    Loffler CA; Macdougall C
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):961-81. PubMed ID: 18039081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating Central Catheter-Associated Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Beyond Vancomycin.
    Holt S; Thompson-Brazill KA; Sparks ER; Lipetzky J
    Crit Care Nurse; 2016 Aug; 36(4):46-57. PubMed ID: 27481801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of Staphylococcus aureus bacteraemia.
    Mitchell DH; Howden BP
    Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antimicrobial agents for methicillin-resistant Staphylococcus aureus.
    Kollef MH
    Crit Care Resusc; 2009 Dec; 11(4):282-6. PubMed ID: 20001879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Staphylococcus aureus bacteraemia.
    Tabah A; Laupland KB
    Curr Opin Crit Care; 2022 Oct; 28(5):495-504. PubMed ID: 35942696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
    Barber KE; Rybak MJ; Sakoulas G
    J Antimicrob Chemother; 2015 Jan; 70(1):311-3. PubMed ID: 25125677
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Management of
    McMullan BJ; Campbell AJ; Blyth CC; McNeil JC; Montgomery CP; Tong SYC; Bowen AC
    Pediatrics; 2020 Sep; 146(3):. PubMed ID: 32759380
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of infections due to resistant Staphylococcus aureus.
    Anstead GM; Cadena J; Javeri H
    Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftobiprole versus daptomycin in
    Hamed K; Engelhardt M; Jones ME; Saulay M; Holland TL; Seifert H; Fowler VG
    Future Microbiol; 2020 Jan; 15(1):35-48. PubMed ID: 31918579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial prescribing for treatment of serious infections caused by Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in pediatrics: an expert review.
    Avedissian SN; Rhodes NJ; Shaffer CL; Tran L; Bradley JS; Le J
    Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1107-1116. PubMed ID: 33554692
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia.
    Weis S; Kesselmeier M; Davis JS; Morris AM; Lee S; Scherag A; Hagel S; Pletz MW
    Clin Microbiol Infect; 2019 Jul; 25(7):818-827. PubMed ID: 30928559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.